Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.

Details

Serval ID
serval:BIB_A3E713D81992
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
Title
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.
Journal
Journal of the European Academy of Dermatology and Venereology
Author(s)
Ring J., Worm M., Wollenberg A., Thyssen J.P., Jakob T., Klimek L., Bangert C., Barbarot S., Bieber T., de Bruin-Weller M.S., Chernyshov P.V., Christen-Zaech S., Cork M., Darsow U., Flohr C., Fölster-Holst R., Gelmetti C., Gieler U., Gutermuth J., Heratizadeh A., Hijnen D.J., von Kobyletzki L.B., Kunz B., Paul C., De Raeve L., Seneschal J., Simon D., Spuls P.I., Stalder J.F., Svensson A., Szalai Z., Taieb A., Torrelo A., Trzeciak M., Vestergaard C., Werfel T., Weidinger S., Deleuran M.
ISSN
1468-3083 (Electronic)
ISSN-L
0926-9959
Publication state
Published
Issued date
06/2021
Peer-reviewed
Oui
Volume
35
Number
6
Pages
e362-e365
Language
english
Notes
Publication types: Letter
Publication Status: ppublish
Abstract
Since the introduction of active vaccination against SARS-CoV-2 infection, there has been a debate about the risk of developing severe allergic or anaphylactic reactions among individuals with a history of allergy. Indeed, rare cases of severe allergic reactions have been reported in the United Kingdom and North America. By february 2021 a rate of 4,5 severe allergic reactions occurred among 1 million patients vaccinated with the mRNA-based COVID-19 vaccines, which is higher than the generally expected rate of severe allergic reactions to vaccinations of around 1 in 1 million.
Keywords
Anaphylaxis, COVID-19, COVID-19 Vaccines, Dermatitis, Atopic/prevention & control, Humans, SARS-CoV-2, Vaccines
Pubmed
Web of science
Open Access
Yes
Create date
30/03/2021 11:46
Last modification date
01/06/2021 6:36
Usage data